Acquisition / mergerNotableFiled on BSE ·

J. B. Chemicals & Pharmaceuticals Ltd. Amalgamation Scheme with Torrent Pharmaceuticals

Torrent Pharmaceuticals · Pharmaceuticals & Biotechnology

Arthneeti Research DeskPublished 1 min read

Key highlights

  • Scheme of Amalgamation filed for merger of J. B. Chemicals & Pharmaceuticals Limited (Transferor) with Torrent Pharmaceuticals Limited (Transferee).
  • Shareholding patterns confirm no partly paid shares, convertible securities, warrants, depository receipts, or pledged promoter shares; locked-in shares present as of March 31, 2023-2025.
  • Nil complaints reported during complaint periods from July 2025 to December 2025; SEBI and stock exchange observations incorporated with compliance requirements and disclosures outlined for NCLT filing by February 17, 2026.

Why it's rated notable: The scheme is a proposal that needs an equity shareholder vote on April 28, 2026 and Tribunal sanction, so it is not binding, and the filing states no value for the scheme, so the level stays at medium.

Original filing

Notice To Equity Shareholders For NCLT Convened Meeting

Read the filing on BSE (PDF) →

Companies guiding to strong growth

Ranked by management's own guidance on revenue and margins — not by us.

Rossell Techsys

Aerospace & Defense

Revenue growth 40%+Margin up 2%+

Sign up free to see all 6 →

See full rankings

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

More from Torrent Pharmaceuticals

Other acquisition / merger filings this fortnight

All acquisition / merger filings →

Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.